CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $132K of Crinetics Pharmaceuticals, Inc.
Sold$131,580
$43.86Price
3,000Shares
−3%Stake
What CRNX did after the filing
- The stock from Tue, Jun 11 close, $44.82
- +19.0%
- S&P 500, same days
- +0.6%
Measured over 30 trading days, to the Jul 25 close.
Traded Mon, Jun 10. Filed Tue, Jun 11, 12:35 PM ET, during the session. Returns use the Jun 11 close and the Jul 25 close. Not investment advice.